0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Yes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaborationJoin our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessThrough this methodology, healthcare authorities should be able to quantify the population eligible to a new licensed medication, such as SGLT-2 inhibitors, and to simulate scenarios to assess reimbursement criteria according to precise estimates.
Francesco Lapi, Elisa Bianchini, Ettore Marconi, Gerardo Medea, Carlo Piccinni, Aldo Maggioni, Letizia Dondi, Antonella Pedrini, Nello Martini, Claudio Cricelli (2023). A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes. , 32(10), DOI: https://doi.org/10.1002/pds.5641.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2023
Authors
10
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1002/pds.5641
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free Access
